<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To test the <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> hypothesis in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) patients and to identify possible associations with clinical and laboratory features of the disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Serum amyloid A (SAA), C-reactive protein (CRP), <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> and <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="26338">PGE</z:chebi>) were assayed in the sera of 45 APS patients and then compared to control groups made up of 15 <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> (aPL) negative patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, 15 aPL negative subjects with pregnancy-related morbidity, 15 aPL negative patients with <z:mp ids='MP_0005048'>thrombosis</z:mp>, 15 subjects with persistently positive aPL with no signs or symptoms of APS, and 15 healthy volunteers from among the hospital staff </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: APS patients showed significantly higher CRP (p = 0.01), SAA (p &lt; 0.01), <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> (p = 0.05) and <z:chebi fb="0" ids="15551">PGE2</z:chebi> (p = 0.001) plasma levels as compared to controls </plain></SENT>
<SENT sid="3" pm="."><plain>Among APS subjects, significantly higher <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> and <z:chebi fb="0" ids="15551">PGE2</z:chebi> levels were observed in patients with triple positivity for aPL (<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies) compared to APS patients with single or double aPL positivity </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Both <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0003674'>oxidative stress</z:mp>, as measured by SAA, CRP, <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> and <z:chebi fb="0" ids="15551">PGE2</z:chebi>, occur in APS and seem to be related to triple positivity for aPL </plain></SENT>
</text></document>